The new “2022 Glaucoma Surgical Device Market Report” redefines glaucoma surgical products by aqueous drainage location and in accordance with the way surgeons refer to products. It also provides an analysis of the COVID-19 pandemic’s impact on glaucoma surgery and the market’s rebound by year from 2020 to 2027.
The report focuses on novel microstents in various stages of development and commercialization that are expected to be used in more advanced stages of glaucoma, as well as standalone glaucoma surgery, rather than only in combined cataract/glaucoma procedures.
In addition, the report analyzes a handful of novel glaucoma surgery devices that have the potential to dramatically expand glaucoma surgery, including the Alievio adjustable shunt, Avisi Technologies microshunt, CorNeat Vision eShunt, Glaukos iStent Infinite, MicroOptx Beacon shunt, Rheon Medical eyeWatch adjustable shunt, and Sanoculis Minimally Invasive Microsclerostomy (MIMS) device. Further, the report looks at new laser technologies that have the potential to dramatically expand the use of lasers in glaucoma, including the Belkin laser, ViaLase femtosecond laser, Elios ELT Laser, and IOPtimate CO2 laser.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.